AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
+9.47%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$261M
AUM Growth
+$261M
(-2.1%)
Cap. Flow
-$14.9M
Cap. Flow
% of AUM
-5.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Beam Therapeutics
BEAM
|
$14.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Beam Therapeutics
BEAM
$1.66B
| $118M | 45.46% |
4,834,653
-608,386
| -11% | -$14.9M |
|
|
RAPP
2
Rapport Therapeutics
RAPP
$643M
| $76.4M | 29.31% |
3,728,738
| – | – |
|
3
Erasca
ERAS
$445M
| $30.2M | 11.58% |
11,055,554
| – | – |
|
4
Q32 Bio
QTTB
$20.9M
| $14.3M | 5.49% |
320,482
| – | – |
|
|
VERV
5
DELISTED
Verve Therapeutics
VERV
| $9.72M | 3.73% |
2,008,809
| – | – |
|
6
Gossamer Bio
GOSS
$562M
| $7.95M | 3.05% |
8,055,916
| – | – |
|
|
OMIC
7
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.98M | 0.76% |
126,630
| – | – |
|
|
UBX
8
DELISTED
Unity Biotechnology
UBX
| $1.48M | 0.57% |
1,004,817
| – | – |
|
9
CERo Therapeutics
CERO
$9.06M
| $135K | 0.05% |
1,444,296
| – | – |
|